◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Integrated Diagnostics Holdings plc (IDHC) Financial History

Name: Integrated Diagnostics Holdings plc (IDHC) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-08-16

Integrated Diagnostics Holdings plc (IDHC) operates in the Diagnostics & Research industry and is headquartered in Saint Helier, Jersey with about 7,137 employees. Its market capitalization is roughly EGP 311 million. In the fiscal year ended 2025-12-31, IDHC reported EGP 7.9B in revenue and EGP 1.3B in net income.

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides medical diagnostics services to patients.

Interactive charts & full statements →

IDHC Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total Revenue	EGP 7.9B	EGP 5.7B	EGP 4.1B	EGP 3.6B
Gross Profit	EGP 3.4B	EGP 2.2B	EGP 1.5B	EGP 1.5B
Operating Income (EBIT)	EGP 2.1B	EGP 1.2B	EGP 790M	EGP 873M
Net Income	EGP 1.3B	EGP 1.1B	EGP 510M	EGP 541M

EGP; EGPM / EGPB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IDHC Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-03-31
Total Revenue	EGP 2.1B	EGP 1.6B
Gross Profit	EGP 807M	EGP 631M
Operating Income (EBIT)	EGP 458M	EGP 365M
Net Income	EGP 437M	EGP 245M

EGP; EGPM / EGPB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IDHC Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(EGP 535M)	(EGP 27M)	—	(EGP 1.4B)	(EGP 479M)

EGP; EGPM / EGPB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

IDHC Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	EGP 8.6B	EGP 7.1B	EGP 5.8B	EGP 5.3B	—
Total Liabilities	EGP 4.5B	EGP 3.6B	EGP 2.7B	EGP 2.8B	—

EGP; EGPM / EGPB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive IDHC viewer.

Other Companies in Diagnostics & Research

CSTL · Castle Biosciences, Inc. — $979 million
LBIRD · Lumibird SA — $626 million
FLGT · Fulgent Genetics, Inc. — $527 million
EDT · Spectral Medical Inc. — $405 million
MYGN · Myriad Genetics, Inc. — $290 million
BDSX · Biodesix, Inc. — $253 million
0767 · Zhong Ji Longevity Science Group Limited — $248 million
0928 · King International Investment Limited — $185 million

← IDEV All “I” companies IDIA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.